Of the 32 differentially co-expressed genes, the products of CCT7, EPS15, STRN4, SRPRB, GPI, and RAPH1 could be considered additional candidates for therapeutic interventions due to their mechanistic relevance for asthma and airway remodeling and their high connectivity in the related protein–protein interaction networks. This evidence concerns the gene RAPH1 and asthma.